Tech Company Financing Transactions
NVision Quantum Funding Round
NVision Quantum, based in Ulm, raised $55 million in investment from Abbott Laboratories, b2venture and Entree Capital.
Transaction Overview
Company Name
Announced On
5/13/2026
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series B
Investors
Proceeds Purpose
Th company intends to use the funds toexpand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Wolfgang-Paul-Straße 2
Ulm, 89081
Germany
Ulm, 89081
Germany
Phone
Website
Email Address
Overview
Quantum technologies are set to redefine the boundaries of science, technology, and medicine. At NVision, we lead this transformation by mastering quantum spin control in organic molecules - a unique capability that powers both our quantum computing and quantum-enhanced sensing platforms.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/13/2026: Hacktron venture capital transaction
Next: 5/13/2026: 9amHealth venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








